SCHEMBL4848161

SCHEMBL4848161

[CH2]CC(=O)OCC(OCC)OCC

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MGAM O43451 1/20 0.34
GAA P10253 1/20 0.34
SI P14410 1/20 0.34
MGAM2 Q2M2H8 1/20 0.34
ALDH1A1 P00352 4/20 0.32
TRPA1 O75762 1/20 0.32
MAPT P10636 1/20 0.32
LMNA P02545 3/20 0.31
HSD17B10 Q99714 1/20 0.31
CYP3A4 P08684 1/20 0.31
TSHR P16473 1/20 0.31
ATM Q13315 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
ALOX15 P16050 1/20 0.30
KDM4E B2RXH2 1/20 0.30
DUSP3 P51452 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
SOAT1 P35610 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4856239 0.90 MGAM (0.31) MGAMGAASIMGAM2
SCHEMBL8894699 0.88 ALDH1A1 (0.36) ALDH1A1MAPTLMNACYP3A4TSHR
SCHEMBL4849685 0.84 MAPT (0.37) MGAMGAASIMGAM2ALDH1A1
SCHEMBL5663644 0.83 NAAA (0.39) MGAMGAASIMGAM2ALDH1A1
SCHEMBL6276290 0.83 MGAM (0.54) MGAMGAASIMGAM2ALDH1A1
SCHEMBL297785 0.83 MAPT (0.41) MGAMGAASIMGAM2ALDH1A1
SCHEMBL10923832 0.79 MAPT (0.47) ALDH1A1MAPTLMNACYP3A4TSHR
SCHEMBL1842052 0.79 ALDH1A1 (0.44) ALDH1A1MAPTLMNACYP3A4TSHR
SCHEMBL522535 0.79 MAPT (0.52) ALDH1A1MAPTLMNACYP3A4TSHR
SCHEMBL28122801 0.78 ALDH1A1 (0.50) MGAMGAASIMGAM2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7329694-B2 Ocular lens JOHNSON & JOHNSON VISION CARE, INC. (US) 2008-02-12 US disclosed
EP-1445641-B1 OCULAR LENS JOHNSON & JOHNSON VISION CARE (US) 2007-10-03 EP disclosed
US-20040201820-A1 Ocular lens JOHNSON & JOHNSON VISION CARE, INC. 2004-10-14 US disclosed
US-20040198938-A1 Monomers, polymers and ophthalmic lenses JOHNSON & JOHNSON VISION CARE, INC. 2004-10-07 US disclosed
EP-1445641-A1 OCULAR LENS Johnson & Johnson Vision Care, Inc. (US) 2004-08-11 EP disclosed
EP-1424339-A1 MONOMERS, POLYMERS AND OPHTHALMIC LENSES Johson & Johnson Vision Care Inc. (US) 2004-06-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040198938-A1 Monomers, polymers and ophthalmic lenses LOXL1, CRYAA, UACA MGAM 1176/4885GAA 3218/4885SI 4436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.